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Abstract
Background: Despite recent improvements, uptake and retention of mothers and infants in prevention of
mother-to-child transmission (PMTCT) services remain well below target levels in many low- and middle-income
countries (LMICs). Identification of effective interventions to support uptake and retention is the first step towards
improvement. We aim to complete a systematic review and meta-analysis to evaluate the effectiveness of
interventions at the patient, provider or health system level in improving uptake and retention of HIV-infected
mothers and their infants in PMTCT services in LMICs.
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Methods/Design: We will include studies comparing usual care or no intervention to any type of intervention to
improve uptake and retention of HIV-infected pregnant or breastfeeding women and their children from birth
to 2 years of age attending PMTCT services in LMICs. We will include randomized controlled trials (RCTs), cluster
RCTs, non-randomized controlled trials, and interrupted time series. The primary outcomes of interest are
percentage of HIV-infected women receiving/initiated on anti-retroviral prophylaxis or treatment, percentage of
infants receiving/initiated on anti-retroviral prophylaxis, and percentage of women and infants completing the
anti-retroviral regimen/retained in PMTCT care. The following databases will be searched from inception: Ovid
MEDLINE and EMBASE, The WHO Global Health Library, CAB abstracts, EBM Reviews, CINAHL, HealthSTAR and
Web of Science databases, Scopus, PsychINFO, POPLINE, Sociological Abstracts, ERIC, AIDS Education Global
Information System, NLM Gateway, LILACS, Google Scholar, British Library Catalogue, DARE, ProQuest Dissertation
& Theses, the New York Academy of Grey Literature, Open Grey, The Cochrane Library, WHO International Clinical
Trials Registry, Controlled Clinical Trials, and clinicaltrials.gov. Reference lists of included articles will be hand
searched and study authors and content experts contacted to inquire about eligible unpublished or in progress
studies. Screening, data abstraction, and risk of bias appraisal using the Cochrane Effective Practice and
Organization of Care criteria will be conducted independently by two team members. Results will be synthesized
narratively and a meta-analysis conducted using the DerSimonian Laird random effects method if appropriate
based on assessment of clinical and statistical heterogeneity.
Discussion: Our findings will be useful to PMTCT implementers, policy makers, and implementation researchers
working in LMICs.
Systematic review registration: PROSPERO CRD42015020829
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Background
Although the incidence of pediatric HIV acquisition is
falling, over 240,000 children were newly infected with
HIV in 2013, primarily through mother-to-child trans-
mission [1]. Prevention of mother-to-child transmission
(PMTCT) therapeutic regimens have been proven to
reduce the risk of mother-to-child transmission from
20–45 % to 2 % in non-breastfeeding populations and
5 % or less in breastfeeding populations [2]. However,
despite recent improvements in PMTCT clinical service
coverage in low- and middle-income countries (LMICs)
from 10 % in 2004 to 67 % in 2013, uptake and retention
of mothers and newborns in PMTCT clinical services re-
main well below target levels in many LMICs [1, 2].
PMTCT services begin with maternal HIV testing and
counseling and for HIV-infected women include the
following: initiation and maintenance of pregnant and
nursing women and their infants on PMTCT medica-
tion regimens for the duration of treatment as defined
by the specific regimen employed; and completion of
appropriate infant HIV testing. As a result of the
2010–2015 PMTCT strategic vision, the World Health
Organization (WHO) has called for renewed commit-
ment and effort towards achieving universal PMTCT
coverage. The identification of interventions to sup-
port PMTCT uptake and retention is the first step to-
wards improvement.
To date, two systematic reviews have been published
that specifically evaluated the effectiveness of interven-
tions to improve PMTCT coverage. Both were limited to
specific interventions—male involvement [3] and integra-
tion of services [4] —and found too few studies meeting
inclusion criteria to assess or make recommendations re-
garding effectiveness. A third systematic review indentified
nine completed studies and five ongoing trials which ex-
amined initiation of antiretroviral (ARV) treatment in
pregnant women [5]. While the authors report several
promising interventions for improving ARV initiation, the
quality of evidence was insufficient to support recommen-
dations. In addition, results for ARV initiation in pregnant
women were not independently examined, and maternal
retention in PMTCT care and exposed infant care were
not assessed. However, in our preliminary search, we iden-
tified a number of additional interventions including inte-
gration of HIV and antenatal care, peer-based programs,
and community health worker programs [6–8] that have
been evaluated to improve PMTCT uptake and retention
in LMICs.
Given the paucity of synthesized evidence to date, we
propose to complete a systematic review to identify what
interventions are effective in improving uptake and re-
tention of HIV-infected mothers and their infants in
PMTCT services in LMICs. While we anticipate a
relatively small number of evaluations of any given
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intervention type, which may preclude meta-analysis, a
narrative synthesis of the evidence to date is urgently
needed to inform LMIC PMTCT program development
and policy. With the exception of Option B+ (lifelong
triple ARV therapy for all HIV+ pregnant and breast-
feeding women, regardless of clinical stage or CD4
count) recommended by WHO in April 2012 for which
evidence is not yet available, the effectiveness of PMTCT
regimens is well established and will therefore not be in-
cluded in the present search [9].
Methods/Design
Protocol
A preliminary systematic review protocol was developed
based on the Cochrane Handbook [10]. The protocol
was revised with input from the PURE Malawi Consor-
tium, a research partnership of governmental, non-
governmental, and academic organizations working to
improve PMTCT programming in Malawi. The final
protocol was registered with the PROSPERO database
(CRD42015020829, available at: http://www.crd.york.ac.
uk/PROSPERO/display_record.asp?ID=CRD4201502082
9#.VXHCNUZBn5I), with reporting of the protocol
guided by the PRISMA-P [11].
Eligibility criteria
We will include studies of HIV-infected pregnant and
breastfeeding women and their children from birth to
2 years of age or termination of breastfeeding in LMICs.
For the purpose of this review, we will utilize the EPOC
filter to identify low- and middle-income countries [12]
updated using the most recent World Bank World
Country and Lending group classification [13] to define
LMICs. Based on the unique challenges facing PMTCT
health services in LMICs and intended use of the find-
ings of this review to inform PMTCT service develop-
ment in Malawi and other LMICs, we chose to limit the
review to studies conducted in LMICs. Studies con-
ducted only in high-income countries or where LMIC
results cannot be separated will not be eligible for
inclusion.
We will include studies comparing usual care or no
intervention to any type of intervention (including pa-
tient, provider, or health system level interventions) to
improve uptake and retention of HIV-infected pregnant
or breastfeeding women and their children from birth to
2 years of age in PMTCT services. Patient level interven-
tions are those focused on the patient and may include
patient education programs, peer support programs, or
efforts to improve patient support through engagement
of partners or family members. Provider level interven-
tions may include provider training, incentive programs,
or tools to improve care provided. Health system level
interventions may include restructuring of services and
task shifting or other mechanisms to address human re-
source shortages.
The primary outcomes of interest are percentage of
HIV-infected women receiving or initiated on ARV
prophylaxis or treatment, percentage of infants born to
HIV-infected mothers receiving or initiated on ARV
prophylaxis, and percentage of women and infants
retained in PMTCT care/completing the ARV regimen as
defined by the PMTCT regimen utilized. Secondary out-
comes of interest include the following: percentage of in-
fants completing post-exposure HIV testing at 4–6 weeks
after birth and percentage of infants completing post-
exposure HIV testing at 6 weeks following termination of
breastfeeding for all infants with known HIV exposure as
recommend by the WHO [14]; percentage of HIV-
exposed infants testing positive for HIV; and adverse
events including negative impact(s) on resources/delivery
and/or effectiveness of other health care programs (in-
cluding economic impact), major (e.g., heart defects,
neural tube defects, major limb malformations, hypospa-
dias) or minor (e.g., syndactyly, cutis aplasia, accessory
digit) congenital malformations, small for gestational age,
premature delivery, still birth, and infant death within the
first 2 years of life).
We will include controlled experimental studies (ran-
domized controlled trials, cluster randomized controlled
trials, non-randomized controlled trials) and controlled
quasi-experimental studies (interrupted time series). We
chose to include non-randomized controlled trials and
quasi-experimental designs based on the results of our
scoping searches, in which we found few randomized
controlled trials that evaluated interventions to improve
uptake and retention of HIV-infected women and their
children in PMTCT services conducted in LMICs. Lan-
guage of publication will be restricted to the language
spoken by the study team and includes English only. No
restrictions will be placed on publication status, study
time frame, or duration of follow-up.
Information sources and literature search
Our search strategy was developed in consultation with
an experienced information specialist and peer reviewed
by two additional information specialists with expertise
in systematic reviews using the Peer Review of Elec-
tronic Search Strategies checklist [15].
We will search the following electronic databases from
inception to June 2015 using medical subject headings
(MeSH) and text words related to HIV, pregnancy, breast-
feeding, mother-to-child transmission, interventions, treat-
ment uptake and retention, and low- and middle-income
countries, using MEDLINE (OVID interface, 1946 to July
Week 4 onwards), EMBASE (OVID interface, 1974 on-
ward), The WHO Global Health Library (http://www.glo-
balhealthlibrary.net/php/index.php), CAB abstracts (OVID
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interface, 1973 onward), EBM Reviews (OVID interface,
1991 onward), CINAHL (EBSCOhost Research Databases
interface, 19,814 onward), HealthSTAR (OVID interface,
1966 onward) and Web of Science databases (Thompson
Reuters interface, 1975 onward), Scopus (Elsevier Interface,
1823 onward), PsychINFO (OVID interface, 1806 onward),
POPLINE (www.POPLINE.org, 1970 onward), Socio-
logical Abstracts (Proquest interface, 1953 onward),
ERIC (EBSCOhost Research Databases interface, 1966
onward), AIDS Education Global Information System
(http://www.aegis.org), NLM Gateway (http://gateway.
nlm.nih.gov/), LILACS (http://bases.bireme.br/cgi-bin/
wxislind.exe/iah/online/?IsisScript=iah/iah.xis&base=LI
LACS&lang=i), Google Scholar (https://scholar.google.
ca), British Library Catalogue (http://explore.bl.uk/pri-
mo_library/libweb/action/search.do?dscnt=1&dstmp=144
5538063587&vid=BLVU1&fromLogin=true), DARE (Lex-
isNexis Academic interface, 2010 onward), ProQuest Dis-
sertation & Theses (Proquest Interface, 1637 onward), the
New York Academy of Grey Literature (http://library.
tmc.edu/website/new-york-academy-of-medicine-library-
grey-literature-collection/), OpenGrey (http://www.open-
grey.eu/), The Cochrane Library (http://www.cochraneli-
brary.com/), WHO International Clinical Trials Registry
(http://www.who.int/ictrp/en/), Controlled Clinical Trials
(http://www.controlled-trials.com/), and clinicaltrials.gov
(https://clinicaltrials.gov/). In addition, we will search ref-
erence lists of included articles and will contact experts in
the field to inquire about eligible unpublished or in pro-
gress studies. Low- and middle-income countries will be
searched utilizing the EPOC LMIC filter [12], updated
based on the most recent World Bank LMIC list [13], see
Additional file 1 for full MEDLINE search strategy. We
will employ the Cochrane highly sensitive search strategy
for identifying randomized trials in OVID MEDLINE: sen-
sitivity and precision maximizing version [16], with the
following two changes: Random* was used in place of ran-
domized or randomly and trials ti was not used as an iso-
lated term.
Study selection process
All titles and abstracts identified by the database search
will be entered into a reference manager and duplicates
removed manually into the duplicate folder, with com-
panion papers for the same study retained for further
evaluation at the full article phase of the review. Cita-
tions will be screened in two phases, level 1 (titles and
abstracts) and level 2 (full-text review). A screening
checklist will be developed and pilot tested by the re-
viewers on a random sample of 50 citations for each
screening phase. Inter-rater agreement will be calculated
for the pilot test and the form revised and re-piloted if
percent agreement is <90 %. Once adequate agreement
has been achieved, two team members will independently
screen citations using the screening checklist. Differences
at each stage will be resolved by consensus and if neces-
sary through discussion with a third team member who is
a content expert. Reference lists of included studies will be
reviewed independently by the same two team members
and again differences resolved through consensus and if
necessary consultation with a third team member. A re-
view log will be maintained in order to provide a record of
resolution of discrepancies, decisions regarding studies de-
scribed in >1 report, and reasons for exclusion.
Data abstraction and management
Data abstraction forms will be developed and pilot
tested. Two team members will independently abstract
directly into excel spreadsheets, corresponding to out-
come tables, with additional space for comments and
reasons for exclusion. Inter-rater reliability will be mea-
sured for data abstraction on a sample of excluded and
included articles (approximately 10 %), and if percent
agreement is found to be below 90 %, abstraction is con-
ducted by a third team member. All discrepancies will
be reviewed and consensus reached through discussion.
Data abstraction will be based on the PICOST [17]
format including population, intervention, comparator,
context, outcomes, study DESIGN, and time frame.
Population characteristics to be abstracted include ma-
ternal age, number of children, marital status, place of
residence (rural/urban), level of education, primary lan-
guage, first infant HIV testing (4–6 weeks), and at end
of study. Study characteristics of interest include study
design, country and geographical location within country
(rural/urban), setting (home, hospital or health center
clinic, maternity ward), detailed description of interven-
tion and comparator (usual care/no intervention), num-
ber of participants per group at study baseline and
follow-up, duration of intervention and follow-up period,
source of data (self-report, clinical records, pill count-
ing), and publication status. Outcome data to be ab-
stracted include percentage of HIV-infected women and
their infants receiving or initiating PMTCT treatment,
retained in or completing PMTCT as defined by the
PMTCT regimen(s) used. Where data necessary for
analysis are missing, corresponding authors will be
contacted.
Although improved in recent years, examples of clus-
ter trails inappropriately analyzed (without adjustment
for cluster randomization) may be found among older
trials. Data on appropriateness of analysis will be ab-
stracted and reported as part of the review findings.
Methodological quality/risk of bias appraisal
Risk of bias assessment will be conducted using the
Cochrane Effective Practice and Organization of Care
(EPOC) criteria for assessing risk of bias [18]. Categories
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of bias assessed by this tool for randomized controlled
trials, and non-randomized controlled trails include: al-
location concealment, measurement of baseline charac-
teristics and outcomes, management of incomplete data,
blinding of outcome assessment, protection against con-
tamination, selective reporting, and other categories of
bias [18]. Categories of bias assessed by this tool for
interrupted time series and repeated measures studies
include independence of intervention from other
changes, pre-specification of the intervention effect
shape, effect of data collection on the intervention, allo-
cation concealment, management of incomplete data, se-
lective reporting, and other sources of bias [18]. Two
team members will independently assess the studies for
risk of bias at both study and outcome levels with dis-
agreement resolved by consensus and discussion with a
third team member if necessary. Studies will not be
excluded based on risk of bias assessment, but the infor-
mation will be used in the analysis and reporting of find-
ings. Risk of bias will be categorized as low, high, or
unclear risk of bias, using the EPOC-suggested risk of
bias criteria [18]. We have elected not to use GRADE
for this review given that the review findings are ur-
gently needed to inform PMCTC program development
and policy and that the need to build capacity in the use
of grade across the team which would significantly pro-
long the review timeline.
Risk of publication bias will be examined using funnel
plots. For studies in which selected reporting bias is sus-
pected, planned outcomes will be reviewed for registered
trials and authors contacted for missing outcomes and
for unregistered trials, and risk of selected reporting bias
rated as unclear if response not received within 8 weeks
of our initial email request.
Evidence synthesis
A flow diagram will be utilized to visually present the re-
sults of the search strategy and reasons for exclusion of
articles. Included articles will be synthesized and re-
ported narratively and in tabular form to provide an
overview of findings, assessment of bias and its potential
impact on reported findings, and strengths and weak-
nesses of included studies. Summary statistics for con-
tinuous outcomes will be expressed as mean difference
and standardized mean difference with 95 % CIs, for
outcomes reported using the same and different scales,
respectively. Summary statistics for dichotomous data
will be expressed as risk ratio with 95 % CI.
If meta-analysis is possible, it will be conducted using
the DerSimonian Laird random effects method. Summary
statistics will be expressed as risk ratios with 95 % confi-
dence interval. Clinical heterogeneity will be determined
based on patient, intervention, and outcome characteris-
tics of included studies. Statistical heterogeneity will be
determined visually and the impact of heterogeneity
assessed using the I2 test, with I2 of 75 % considered
significant. Given the time constraints for this review, re-
analysis for unit of analysis errors will not be conducted
and cluster trials with unit of analysis errors will be ex-
cluded from the primary meta-analysis, and their impact
assessed with sensitivity analysis comparing meta-analysis
with and without studies with unit of analysis errors in-
cluded. Interventions at the patient, provider, and health
system level will be reported separately and analyzed sep-
arately if possible to do so.
Discussion
The findings of this review will have significant implica-
tions for PMTCT program development and policy in
LMICs. If high-quality evidence of intervention effective-
ness is identified, this will provide important guidance to
ongoing efforts to address low rates of uptake and reten-
tion of HIV-infected mothers and their infants in
PMTCT services in LMICs. If high-quality evidence is
not identified, findings of the systematic review may
identify gaps in evidence and promising interventions
providing direction for future intervention research.
To ensure our findings reach audiences who may
benefit from the review findings, we plan to disseminate
the results through publication in open access peer-
reviewed journals, presentations at relevant international
conferences, and direct communication within the pro-
fessional networks of PURE consortium members.
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